Home » Topics » Regulatory

Regulatory
RSS

FDA approves Duaklir for maintenance treatment of COPD

April 1, 2019

Cimzia becomes the first and only FDA-approved treatment for nonradiographic axial spondyloarthritis

March 29, 2019

Foscavir approved in Japan to treat HHV-6 encephalitis

March 27, 2019

AnGes obtains conditional approval in Japan for HGF plasmid in critical limb ischemia

March 27, 2019

Revcovi approved in Japan for ADA deficiency

March 27, 2019

FDA approves Mayzent for relapsing forms of MS

March 27, 2019

Vyndaqel approved in Japan for transthyretin amyloid cardiomyopathy

March 26, 2019

Japan first to approve Skyrizi for psoriasis indications

March 26, 2019

Smyraf approved in Japan to treat rheumatoid arthritis

March 26, 2019

European Commission approves Forxiga for type 1 diabetes

March 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...